Ankle Syndesmosis Treatment Device Market
Ankle Syndesmosis Treatment Device Market Study by Syndesmosis Implant Systems, Plate Kits, and Clamps for Ankle Fractures, Syndesmosis Reduction, and Postoperative Management from 2024 to 2034
Analysis of Soil Fertility Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Ankle Syndesmosis Treatment Device Market Outlook (2024 to 2034)
Fact.MR, in its new study, reveals that the global ankle syndesmosis treatment device market is estimated at US$ 184.8 million in 2024. Worldwide sales of ankle syndesmosis treatment devices are forecasted to rise at 7.9% CAGR and reach US$ 396.7 million by the end of 2034.
Rising incidence of sports-related injuries, especially ankle injuries among athletes, is forecasted to contribute to the demand growth for efficient treatment devices used to treat ankle syndesmosis injuries. In addition, ongoing technological advancements are projected to lead to the development of several innovative ankle syndesmosis treatment devices. Ankle braces, surgical instruments, and implants are some of these popular options, which ensure quicker recovery and better stability.
Increasing involvement of more individuals in fitness and sports activities is leading to the rising chances of ankle injuries, which fuels the demand for specialized treatment, thus contributing to rising sales of ankle syndesmosis treatment devices. Elderly people are more prone to musculoskeletal injuries and issues, including ankle syndesmosis injuries. These disorders lead to the requirement for ankle syndesmosis treatment devices for better rehabilitation and support.
- Demand for ankle syndesmosis treatment devices in East Asia is projected to increase at a 7.6% CAGR and reach U$ 53 million by the end of 2034.
- Syndesmosis implant systems are expected to account for 53.9% share of the global market by 2034.
- Sales of biodegradable material-based implants are forecasted to rise at an exceptionally high CAGR of 51.1% and reach US$ 192.4 million by 2034.
Growing awareness among patients and healthcare professionals about the importance of appropriate diagnosis and treatment used for ankle syndesmosis injuries is expected to encourage the adoption of ankle syndesmosis treatment devices. Furthermore, increasing preference for minimally invasive surgeries is set to lead to innovations in ankle syndesmosis treatment devices.
In recent years, there has been an increasing emphasis on efficient post-operative rehabilitation methods and care, which is driving demand for respective supportive devices to aid in quick healing and recovery process after surgery.
| Report Attributes | Details |
|---|---|
| Ankle Syndesmosis Treatment Device Market Size (2024E) | US$ 184.8 Million |
| Forecasted Market Value (2034F) | US$ 396.7 Million |
| Global Market Growth Rate (2024 to 2034) | 7.9% CAGR |
| Ankle Fracture Segment Market Share (2034F) | 55.8% |
| North America Market Share (2034F) | 35.3% |
| Japan Market Growth Rate (2024 to 2034) | 7.4% CAGR |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What’s Set to Push Adoption of Ankle Syndesmosis Treatment Devices Going Ahead?
“High Prevalence of Sports-related Injuries and Rising Awareness About Sustainable Implants”
Worldwide demand for ankle syndesmosis treatment devices is forecasted to increase owing to the growing number of bone disorders and accidents as well as the rising prevalence of infection, bone loss, and joint instability. Recent technological breakthroughs and innovative implant materials are projected to revolutionize the use of these devices. The rising awareness among more surgeons about the benefits of sustainable implant materials is leading to the adoption of biodegradable and titanium implants for the repair of fractures or injuries.
Implants manufactured from titanium are lightweight and offer significant strength. The use of bioabsorbable implants offers several benefits, such as no or minimal irritation of soft tissues, minimal risk of osteopenia, and no requirement for a second process for implant removal. Syndesmotic injuries and ankle fractures are common among sportspeople and athletes. They can get better relief from pain with early diagnosis and treatment as they help in rapid healing. Healthcare providers are focusing on offering more effective treatment options for patients with ankle injuries.
Which Drawbacks of Ankle Syndesmosis Treatment Devices are Adversely Impacting Their Sales Growth?
“Increasing Cases of Foot and Ankle Implant Recall and Strict Regulations Governing Implants”
Rising cases of foot and ankle implant recall are owing to their side effects, infections, manufacturing flaws, and bone loss. Several manufacturers of arthroplasty devices encounter challenges because of the implementation of stringent regulations by respective bodies, including the United States Food and Drug Administration.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are Startups Doing to Secure Their Position in the Market?
“Emphasis on Creation of Eco-friendly and Sustainable Devices”
There is an increasing ankle syndesmosis treatment device market trend to adopt sustainable healthcare solutions. Start-ups need to focus on the use of eco-friendly materials. In addition, they are also experiencing the need to adopt sustainable manufacturing procedures for their respective devices. These initiatives are forecasted to attract individuals who are more environmentally conscious.
Country-wise Insights
North America is projected to hold 35.3% share of the global market by 2034. This growth is attributed to the rising cases of orthopedic diseases, increasing R&D activities to develop patient-specific devices and technological advancements in treatment devices.
What Growth Prospects Await Market Players in the United States?
“Robust R&D Activities Supporting Production of Advanced Devices”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 72 Million |
| Growth Rate (2024 to 2034) | 6.2% CAGR |
| Projected Value (2034F) | US$ 132 Million |
The United States is projected to account for 94.4% share of the North America market by 2034. Rising involvement of market players in the commercialization of ankle syndesmosis treatment devices is expected to positively impact market growth. Further, the increasing application of these implants in fracture fixation is forecasted to contribute to the revenue streams. Manufacturers in the United States are involved in the development of many copolymers, composites, and biodegradable polymers for the replacement of metal implants.
Several domestic companies are investing significantly in R&D activities for the production of novel drugs and product approval. Furthermore, the availability of funding to develop novel technologies is projected to play a pivotal role in ankle syndesmosis treatment device market growth in the United States.
Why is China a Lucrative Market for Ankle Syndesmosis Treatment Device Suppliers?
“High Demand for Lower Extremities Implants and Emphasis on Innovative Therapies”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 11 Million |
| Growth Rate (2024 to 2034) | 8% CAGR |
| Projected Value (2034F) | US$ 23 Million |
China is set to account for 42.8% share of the market in East Asia by 2034. Players in China are actively developing cell therapies and emphasizing novel treatments. Increasing demand for lower extremities plants along with concentration to develop and commercialize implants is forecasted to contribute to the expansion of the ankle syndesmosis treatment device market size in China.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Fact.MR, a market research and competitive intelligence provider, in its newly published study, says that hospitals are set to hold a noteworthy share of market revenue owing to the rising patient population leading to increased hospital admissions. Further, increasing emphasis on early and accurate disease diagnosis in hospitals along with high budget allocation to introduce technologically advanced ankle and foot devices are also contributing to market revenue.
Which Ankle Treatment Device is Widely Used by Surgeons?
“Widespread Adoption of Syndesmosis Implant Systems as Substitute to Metal Implants”
| Attribute | Syndesmosis Implant Systems |
|---|---|
| Segment Value (2024E) | US$ 98.7 Million |
| Growth Rate (2024 to 2034) | 8% CAGR |
| Projected Value (2034F) | US$ 214.02 Million |
Syndesmosis implant systems are projected to hold 53.9% ankle syndesmosis treatment device market share by 2034. The growing sales of these systems are attributed to the increasing demand for titanium-based implants. In addition, increased efforts by players for portfolio expansion are also driving opportunities in the market. Further, constant advancements in biodegradable implants used for fracture fixation are also positively impacting demand for these implants.
Commercialization of syndesmosis implant systems is also projected to contribute to market revenue streams. Further, these biodegradable implants are adopted as an effective substitute for metal implants used for internal fracture fixation.
Which End-use Application of Ankle Syndesmosis Treatment Devices Leads Revenue Generation?
“Rising Use of Ankle Syndesmosis Treatment Devices in Treating Fractures”
| Attribute | Ankle Fractures |
|---|---|
| Segment Value (2024E) | US$ 101.7 Million |
| Growth Rate (2024 to 2034) | 8.1% CAGR |
| Projected Value (2034F) | US$ 221.49 Million |
The ankle fractures segment is forecasted to account for 55.8% share of the market by 2034. The growing prevalence of road and football accidents along with bone disorders is expected to lead to increased cases of ankle fractures. It is one of the prominent applications of ankle syndesmosis treatment devices due to growing awareness about effective surgical procedures.
Competitive Landscape
Creating a strong product portfolio, growing access to premium items, entering into direct and solid customer relationships, and mergers & acquisitions are some initiatives helping players secure their positions. Growing spending to strengthen supply chain management systems, offering quality products, new developments, etc., are forecasted to help players get a competitive edge.
For instance:
- Wright Medical Group entered into an agreement with Stryker in November 2019 for its acquisition. This initiative is set to help Stryker to extend its footprints and accelerate growth opportunities.
Key players in the ankle syndesmosis treatment device market include Arthrex, Inc., Paragon 28, Inc., Mortise Medical, Inion Oy, Breg, Smith & Nephew Plc., Acumed LLC, Wright Medical Group N.V., Exatech, Inc., Infinite Technologies, and Zimmer Biomet Holdings, Inc.
Segmentation of Ankle Syndesmosis Treatment Device Market Research
-
By Product :
- Syndesmosis Implant Systems
- Titanium-based Plate Implants
- Stainless Steel-based Plate Implants
- Biodegradable Material-based Implants
- Syndesmosis Plate Kits
- Syndesmosis Clamps
- Syndesmosis Implant Systems
-
By Application :
- Ankle Fractures
- Syndesmosis Reduction
- Postoperative Management
-
By End User :
- Hospitals
- Ambulatory Settings
- Specialized Orthopedic Clinics
-
By Region :
- North America
- Europe
- East Asia
- Latin America
- Middle East & Africa
- South Asia & Oceania
- FAQs -
What is the valuation of the ankle syndesmosis treatment device market in 2024?
The global ankle syndesmosis treatment device market is estimated at US$ 184.8 million in 2024.
What is the projected size of global by the end of 2034?
Demand for ankle syndesmosis treatment devices is forecasted to reach a market value of US$ 396.7 million by 2034.
At what rate is the ankle syndesmosis treatment device market forecasted to expand?
Sales of ankle syndesmosis treatment devices are forecasted to rise at a CAGR of 7.9% from 2024 to 2034.
What is the forecasted contribution of syndesmosis implant systems to global market revenue?
Syndesmosis implant systems are forecasted to account for 53.9% share of global market revenue by 2034.
At what rate is the demand for ankle syndesmosis treatment devices projected to increase in Japan?
Demand for ankle syndesmosis treatment devices in Japan is projected to accelerate at a CAGR of 7.4% from 2024 to 2034.
Can syndesmosis heal without surgery?
Low-grade syndesmotic injuries can be healed without surgical intervention by limiting mobilization and weight-bearing but surgery helps in rapid recovery.
Ankle Syndesmosis Treatment Device Market